Novavax Appoints Biopharmaceutical Industry Veteran Gregg Alton to Board of Directors
03 nov. 2020 17h32 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax to Host Conference Call to Discuss Third Quarter Financial and Operating Results on November 9, 2020
03 nov. 2020 08h00 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Announces Facility Expansion to Support Global Vaccine Development
02 nov. 2020 08h16 HE
|
Novavax, Inc.
Expands campus with two properties to support vaccine research and development, manufacturing, business operations GAITHERSBURG, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX),...
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
27 oct. 2020 09h03 HE
|
Novavax, Inc.
5,500 volunteers enrolled to date in pivotal Phase 3 clinical trial in the U.K. Study expanded to 15,000 participantsFull enrollment expected by end of NovemberEvent-driven interim data expected as...
Novavax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2020
20 oct. 2020 08h30 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Appoints Leadership Team to Advance NanoFlu through Regulatory Licensure
13 oct. 2020 08h00 HE
|
Novavax, Inc.
Team will focus on global NanoFlu licensure and evaluation of post-pandemic influenza/COVID-19 combination vaccine with NVX-CoV2373 Russell (Rip) Wilson promoted to Executive Vice President and...
Novavax to Participate in Upcoming Conferences
05 oct. 2020 09h00 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Novavax Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax to Present COVID-19, Influenza and RSV Candidate Vaccine Data at World Vaccine Congress Washington 2020
28 sept. 2020 09h00 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Gov. Hogan, Novavax’ Erck, & BIO’s Dr. McMurry-Heath Toured Novavax Labs and Discussed Progress on COVID-19 Vaccine
24 sept. 2020 16h35 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Today, Maryland Governor Larry Hogan and Dr. Michelle McMurry-Heath, President & CEO of Biotechnology Innovation Organization (BIO), joined...
Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom
24 sept. 2020 16h05 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...